15:47 EST FTC seeks to block Sanofi deal with Maze Therapeutics
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SNY:
- Sanofi says Sarclisa Phase 3 trial met primary endpoint
- Sanofi says 12 new molecular entities with ‘blockbuster potential’ in pipeline
- White House to back controversial patent ploy to fight drug costs, STAT says
- Sanofi just downgraded at JPMorgan, here’s why
- Weight-loss drug developers rise after Roche agrees to buy Carmot